Author:
Yadav Samir Shrihari,Sutar Sanjay Raghunath
Reference60 articles.
1. Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer’s disease in the united states and the public health impact of delaying disease onset. Am J Public Health 88(9):1337–1342
2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y et al (2006) Global prevalence of dementia: a delphi consensus study. Lancet 366(9503):2112–2117
3. Ramaroson H, Helmer C, Barberger-Gateau P, Letenneur L, Dartigues J (2003) Prevalence of dementia and Alzheimer’s disease among subjects aged 75 years or over: updated results of the Paquid cohort. Revue neurologique, vol. 159, no. 4, pp. 405–411, 2003
4. Winblad B, Wimo A (1999) Assessing the societal impact of acetylcholinesterase inhibitor therapies. Alzheimer Disease & Associated Disorders, vol 13, pp S9–S19
5. DeKosky ST, Marek K (2003) Looking backward to move forward: early detection of neurodegenerative disorders. Science 302(5646):830–834